by Asmaa Javed | Dec 31, 2017 | Press Releases
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation.
by Asmaa Javed | Dec 31, 2017 | Press Releases
Assuta Medical Center joins an elite group of hospitals skilled in treating Erdheim-Chester disease patients.
by Asmaa Javed | Dec 31, 2017 | Press Releases
The Erdheim-Chester Disease Global Alliance is proud to announce the first ECD Referral Care Center to be located in Australia.
by Asmaa Javed | Dec 31, 2017 | Press Releases
First FDA-Approved drug for this rare disease
by Asmaa Javed | Feb 10, 2017 | Community Chats
